GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.

69.57 0.78 −1.11%
Market cap
$31.8B
P/E
16.0×
Fwd P/E
14.4×
Dividend yield
0.26%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100

GE HealthCare Technologies Inc. 8-K filed Feb 4, 2026

Period ended Feb 4, 2026 · Filed · accepted 6:25 AM ET · Document on sec.gov · Filing index

2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits